Related Experiment Video
Updated: Jul 11, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Mendelian randomization for cardiovascular diseases: principles and applications
Susanna C Larsson1,2, Adam S Butterworth3,4,5,6,7, Stephen Burgess3,4,8
1Unit of Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Mendelian randomization (MR) uses genetic variants to strengthen causal evidence for cardiometabolic risk factors. This approach improves understanding of disease links and drug efficacy in cardiovascular epidemiology.
Area of Science:
- Cardiovascular Epidemiology
- Genetic Epidemiology
- Pharmacogenomics
Background:
- Genome-wide association studies have identified numerous genetic variants linked to cardiometabolic traits.
- Mendelian randomization (MR) leverages these genetic discoveries for causal inference.
Conclusions:
- Mendelian randomization is a powerful tool for establishing causality in cardiometabolic disease research.
- Its application extends to drug development and repurposing within cardiovascular epidemiology.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
08:14Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
Related Concept Videos
Randomized Experiments
Simple randomization
Simple...
Law of Independent Assortment
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Monohybrid Crosses
Dihybrid Crosses
Coronary Artery Disease I: Introduction